SEER, INC. (SEER) Current Ratio
- Current ratio · latest quarter: Value 14.74×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 14.74× | Current assets / current liabilities. $166.10M ÷ $11.27M ≈ 14.74× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 166.10M USD | Assets, Current |
| Current obligations | 11.27M USD | Liabilities, Current |
| Cash and equivalents | 26.07M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 126.78M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 7.66M USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $166.10M | $11.27M | $26.07M | $126.78M | (m) | $7.66M | (m) | (m) | 14.74× |
| 2026-03-31 | $181.59M | $10.24M | $47.32M | $119.35M | (m) | $8.08M | (m) | (m) | 17.73× |
| 2025-12-31 | $201.53M | $15.69M | $47.28M | $138.61M | (m) | $7.79M | (m) | (m) | 12.84× |
| 2025-09-30 | $214.36M | $15.04M | $44.97M | $154.26M | (m) | $8.13M | (m) | (m) | 14.25× |
| 2025-06-30 | $225.64M | $11.79M | $37.93M | $171.90M | (m) | $7.51M | (m) | (m) | 19.15× |
| 2025-03-31 | $255.27M | $13.20M | $52.45M | $187.28M | (m) | $7.07M | (m) | (m) | 19.34× |
| 2024-12-31 | $253.32M | $15.33M | $40.75M | $195.66M | (m) | $7.44M | (m) | (m) | 16.53× |
| 2024-09-30 | $264.10M | $14.38M | $37.62M | $209.98M | (m) | $6.93M | (m) | (m) | 18.36× |
| 2024-06-30 | $299.69M | $17.04M | $31.95M | $251.51M | (m) | $7.58M | (m) | (m) | 17.59× |
| 2024-03-31 | $324.15M | $12.83M | $54.40M | $254.15M | (m) | $5.81M | (m) | (m) | 25.27× |
| 2023-12-31 | $330.51M | $13.22M | $32.50M | $283.73M | (m) | $4.49M | (m) | (m) | 25.00× |
| 2023-09-30 | $346.12M | $12.52M | $36.40M | $294.85M | (m) | $4.22M | (m) | (m) | 27.65× |
| 2023-06-30 | $335.38M | $15.80M | $56.40M | $263.81M | (m) | $5.26M | (m) | (m) | 21.22× |
| 2023-03-31 | $367.38M | $11.75M | $48.39M | $303.71M | $4.74M | $3.72M | (m) | (m) | 31.26× |
| 2022-12-31 | $434.98M | $12.58M | $53.21M | $368.03M | (m) | $4.63M | (m) | (m) | 34.57× |
| 2022-09-30 | $450.47M | $13.62M | $68.07M | $368.00M | $4.54M | $5.92M | (m) | (m) | 33.08× |
| 2022-06-30 | $466.76M | $15.02M | $79.02M | $372.17M | $3.34M | $6.84M | (m) | (m) | 31.07× |
| 2022-03-31 | $457.46M | $11.15M | $225.33M | $219.89M | $2.79M | $3.55M | (m) | (m) | 41.02× |
| 2021-12-31 | $411.70M | $13.42M | $232.81M | $167.26M | $2.50M | $4.14M | (m) | (m) | 30.67× |
| 2021-09-30 | $514.27M | $9.55M | $331.40M | $175.20M | $1.17M | $2.56M | (m) | (m) | 53.83× |
| 2021-06-30 | $525.33M | $8.36M | $370.68M | $147.10M | $896.00K | $2.67M | (m) | (m) | 62.88× |
| 2021-03-31 | $536.24M | $7.40M | $445.76M | $85.38M | (m) | $1.54M | (m) | (m) | 72.50× |
| 2020-12-31 | $433.13M | $8.09M | $333.58M | $98.28M | $0.00 | $551.00K | (m) | (m) | 53.51× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |